Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Faculty of Theology hosts annual meeting of Society for Practical Theology
2015-01-30

From the left are: Prof Yolanda Dreyer (Chairperson of SPTSA, University of Pretoria), Prof Johann Rossouw (UFS), Prof Hussein Solomon (UFS) and Prof Johan Cilliers (Stellenbosch University).
Photo: Michelle Nothling

The privilege of hosting the annual meeting of the Society for Practical Theology in South Africa (SPTSA) fell to the University of the Free State (UFS) this year. Delegates from across the country recently convened on the Bloemfontein Campus to attend the event from 21 – 23 January 2015.

The three-day congress saw several high-profile keynote speakers discussing the topic of ‘Power of religion and religions of power’.

Dr Johann Rossouw from the UFS Department of Philosophy presented a paper on ‘Power, the state and the church in South Africa’. Dr Rossouw regards the cooperation between theologians and philosophers as integral to help us understand the time we live in. Twenty years since the dawn of South Africa’s democracy, “the gap between the country we were promised and the country we received is bigger than ever,” Dr Rossouw said. “A South-African Church … cannot but make her voice heard regarding this gap.”

Expert on conflict resolution and fundamentalism, Prof Hussein Solomon from the UFS Department of Political Studies and Governance scrutinised the compatibility of Islam with democracy. He warned, though, against “the labelling of a conflict as religious on the mere basis of its religious overtones.” Prof Solomon’s paper, ‘Political Islam: trends, trajectory and future prospects,’ not only advocated tolerance and political pluralism, but also pointed to the fact that it is “in the common good of all humanity” to avert a “Clash of Civilizations”.

‘God in granite?’ – Prof Johan Cilliers’ paper – investigated the phenomenon of the monumentalization of religion. Prof Cilliers from Stellenbosch University explained that monuments often have “spiritual character and iconic value, in the sense that it offers a space for the formation or discovery of meaning.” In his presentation he showed, though, that monuments – even those connected to religious motifs – “seldom escape the lure of power”.

The event was organised by the University of the Free State’s Faculty of Theology, Department of Practical Theology.

  

For more information or enquiries contact news@ufs.ac.za .

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept